Invention Grant
- Patent Title: Pyrimidine derivative compound
- Patent Title (中): 嘧啶衍生物化合物
-
Application No.: US10594369Application Date: 2005-03-30
-
Publication No.: US07956060B2Publication Date: 2011-06-07
- Inventor: Hitoshi Arai , Tsutomu Matsumura , Syoichi Isami , Hiroshi Ishida , Koji Hagihara , Hiroshi Umehara , Yoshinori Yamashita , Nana Oiwa , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi
- Applicant: Hitoshi Arai , Tsutomu Matsumura , Syoichi Isami , Hiroshi Ishida , Koji Hagihara , Hiroshi Umehara , Yoshinori Yamashita , Nana Oiwa , Yukimasa Shiotsu , Tomoki Naoe , Hitoshi Kiyoi
- Applicant Address: JP Tokyo
- Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee: Kyowa Hakko Kirin Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Fitzpatrick, Cella, Harper & Scinto
- Priority: JP2004-097434 20040330
- International Application: PCT/JP2005/006034 WO 20050330
- International Announcement: WO2005/095382 WO 20051013
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D471/22 ; C07D487/04 ; C07D239/70 ; C07D471/00 ; C07D487/00 ; C07D401/00 ; C07D403/00 ; C07D405/00 ; C07D409/00 ; C07D411/00 ; C07D413/00 ; C07D417/00 ; C07D419/00 ; A61K31/505 ; A01N43/56

Abstract:
The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y—Z— represents —O—CR3═N— (wherein R3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1 represents —NR10R11 (wherein R10 and R11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2 represents —NR13R14 (wherein R13 and R14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20090012060A1 Antitumor Agent Public/Granted day:2009-01-08
Information query